Sonoma Pharmaceuticals Inc (SNOA) support and resistance · rev $19.5M
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
This page maps Sonoma Pharmaceuticals Inc (SNOA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
SNOA currently screens at market cap $4.9M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SNOA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SNOA quote page for the session range and the stock page for the full model.
Not investment advice.